Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ImmunoGen, Inc.
About IMGN
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its ELAHERE (Mirvetuximab Soravtansine) is a first-in-class ADC targeting folate receptor alpha (FRa), a cell-surface protein over-expressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Its Pivekimab sunirine (PVEK), is an ADC comprised of a high-affinity antibody designed to target CD123 with site-specific conjugation. The Company is advancing PVEK in clinical trials for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and acute myeloid leukemia (AML).
Find out what a historical investment in ImmunoGen, Inc. would be worth today using our IMGN stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy IMGN shares in Australia?
Buying IMGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ImmunoGen, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IMGN
What is the ticker symbol of ImmunoGen, Inc.?
The ticker symbol for ImmunoGen, Inc. is IMGN.
How much is one share of IMGN?
One share of IMGN is valued at $31.24 as of 22 May 2026.
What is the market capitalisation of ImmunoGen, Inc. IMGN?
As of 22 May 2026 ImmunoGen, Inc. has a market cap of -.
What is the 52-week high for ImmunoGen, Inc. stock?
The ImmunoGen, Inc. 52-week high stock price is $NaN.
What is the 52-week low for ImmunoGen, Inc. stock?
The ImmunoGen, Inc. 52-week low stock price is $NaN.
Can I buy IMGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IMGN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IMGN on Stake
- Buy IMGN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of IMGN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
IMGN related stocks